5 min read

UBC Selects Oracle Cloud Safety Technology for its Safety Programs

UBC selected Oracle Life Sciences’ safety case management solution.
UBC selected Oracle Life Sciences' safety case management solution.

AUSTIN, Texas and BLUE BELL, Pa., Aug. 1, 2023 / — United BioSource, LLC (UBC), the leading provider of evidence-based research for the biopharma industry, has migrated its safety functions from on-premises to Oracle Argus Cloud Service, a trusted safety case management solution. UBC specializes in generating real-world evidence of product effectiveness, safety, and value that enable emerging and leading pharmaceutical companies to make medicine and specialty therapies safer and more accessible.

“UBC is committed to helping our clients make informed decisions and optimize the care given to patients using their therapies,” said Nathan Thompson, Chief Information Officer, UBC. “Oracle Argus Cloud Service provides a powerful innovative, agile, and secure technology that can enable us to better manage all safety aspects of even our most complex trials. Using a cloud-based safety solution reduces operational complexities and helps refocus our valuable resources on other parts of the business. We value our ongoing collaboration with Oracle for the development of its next-generation safety technology.”

According to research from Ernst & Young1, large pharmaceutical companies contend with an average of 700,000 adverse event (AE) cases each year. With caseloads and regulations continuously changing, efficient case management and compliance are mission-critical for any organization.

Running on the security and performance of Oracle Cloud Infrastructure, Oracle Argus Cloud Service will provide UBC with state-of-the-art safety case processing for its clinical trials as well as post-marketing programs. With it, UBC can optimize its workflow by automating routine steps, reducing manual work, and cutting processing times. It also enables UBC to address its global compliance goals with aggregated and expedited reporting.

“We are committed to delivering next-generation safety solutions that address the very complex challenges around drug safety and post-market surveillance,” said Seema Verma, Senior Vice President and General Manager, Oracle Life Sciences. “Using Oracle Argus Cloud Service can help position UBC to market its unique capabilities and attract additional business. Because we handle the maintenance in the cloud, we remove some of the risk, time, and challenges that maintaining software on premises can pose so UBC can remain focused on what matters most – working to make medicine and specialty therapies safer and more accessible.”

Oracle Argus Cloud Service is the central location for documenting all data about adverse events including source documents, assessments, and regulatory reports, and it’s the single source of truth for downstream aggregate analytics and signal detection. Oracle Argus Cloud Service can provide UBC with safety case management features and benefits including:

  • Capabilities to help address compliance with global regulations and standards
  • Lower cost and complexity through SaaS deployment
  • Efficient case processing via automation and ease-of-use
  • Powerful, extensible, and user-friendly analytics and reports
  • Lower total cost of ownership

The Safety Innovation Summit Europe 2023 on Oct. 2-3 in Utrecht, Netherlands will outline Oracle’s continuing journey of advancing pharmacovigilance through innovation.

For more information about The Safety Innovation Summit Europe 2023, which is open to all safety professionals involved in pharmacovigilance, click here.

For more information about Oracle Argus Cloud Service, click here. For more information about Oracle Cloud Infrastructure, click here.

About UBC
United BioSource, LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstration safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to make more informed decisions earlier, meet stakeholder requirements, and, ultimately, drive better patient outcomes. For additional information, visit www.ubc.com.

About Oracle Life Sciences
Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years’ experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements – empowering the Life Sciences industry to help improve patient outcomes. Learn more at oracle.com/lifesciences.

About Oracle

Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company–ushering in the new era of cloud computing.

1 Ernst & Young, “How robotics is reshaping the biopharma value chain” – click

Other Recent Posts

5 min read

UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation

This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.
3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.